{"DataElement":{"publicId":"2955919","version":"1","preferredName":"Hematopoietic Cell Laboratory Procedure Performed Hematologic Improvement  Status","preferredDefinition":"A condition or state at a particular time related to the cell line examined to determine hematologic improvement.","longName":"2955894v1.0:2955913v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2955894","version":"1","preferredName":"Hematopoietic Cell Laboratory Procedure Performed","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion.","longName":"HC_LAB_PROC_PRF","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"4025131","version":"1","preferredName":"Hematopoietic Stem Cell Laboratory Procedure","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.):Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","longName":"C12551:C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDF7C3AA-75ED-BD85-E040-BB89AD43728D","latestVersionIndicator":"Yes","beginDate":"2013-12-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-20","modifiedBy":"ONEDATA","dateModified":"2013-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241241","version":"1","preferredName":"Performed","preferredDefinition":"Performed; carried out.","longName":"C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-8839-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A0DDBD-2FCA-7516-E040-BB89AD435BEF","latestVersionIndicator":"Yes","beginDate":"2009-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2009-10-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2955913","version":"1","preferredName":"Hematologic Improvement  Status","preferredDefinition":"Pertaining to or related to the blood and blood-forming organs._A condition superior to an earlier condition._A condition or state at a particular time.","longName":"2955913v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"HI-N","valueDescription":"HI-N Neutrophil Count Increase","ValueMeaning":{"publicId":"3965297","version":"1","preferredName":"HI-N Neutrophil Count Increase","longName":"3965297","preferredDefinition":"neutrophil count increase of greater than or equal to100% from pre-treatment level and an absolute increase of greater than or equal to 500 / mm3","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EC188224-18AC-2C6E-E040-BB89AD43555C","latestVersionIndicator":"Yes","beginDate":"2013-11-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-26","modifiedBy":"SOKKERL","dateModified":"2019-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EC188224-18C4-2C6E-E040-BB89AD43555C","beginDate":"2009-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-26","modifiedBy":"ONEDATA","dateModified":"2013-11-26","deletedIndicator":"No"},{"value":"HI-E","valueDescription":"HI-E Hemoglobin Increase","ValueMeaning":{"publicId":"3965370","version":"1","preferredName":"HI-E Hemoglobin Increase","longName":"3965370","preferredDefinition":"hemoglobin increase of greater than or equal to 1.5 g/dL untransfused; for RBC transfusions performed for Hgb less than or equal to 9.0, reduction in RBC units transfused in 8 weeks by greater than or equal to 4 units compared to the pre-treatment transfusion number in 8 weeks","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EC188224-191D-2C6E-E040-BB89AD43555C","latestVersionIndicator":"Yes","beginDate":"2013-11-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-26","modifiedBy":"SOKKERL","dateModified":"2019-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EC188224-1935-2C6E-E040-BB89AD43555C","beginDate":"2009-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-26","modifiedBy":"ONEDATA","dateModified":"2013-11-26","deletedIndicator":"No"},{"value":"HI-P","valueDescription":"HI-P for pre-treatment of platelet count greater than 20 x 10E9/L","ValueMeaning":{"publicId":"3965371","version":"1","preferredName":"HI-P for pre-treatment of platelet count greater than 20 x 10E9/L","longName":"3965371","preferredDefinition":"for pre-treatment platelet count of > 20 x 10 9L, platelet absolute increase of greater than or equal to 30 x 10 9L; for pre-treatment platelet count of < 20 x 10 9L, platelet absolute increase of greater than or equal to 20 x 10 9L and greater than or equal to 100% from pre-treatment level","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EC188224-193F-2C6E-E040-BB89AD43555C","latestVersionIndicator":"Yes","beginDate":"2013-11-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-26","modifiedBy":"SOKKERL","dateModified":"2019-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EC188224-1957-2C6E-E040-BB89AD43555C","beginDate":"2009-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-11-26","modifiedBy":"ONEDATA","dateModified":"2013-11-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4025133","version":"1","preferredName":"Hematologic Improvement Status","preferredDefinition":"Pertaining to or related to the blood and blood-forming organs.:A condition superior to an earlier condition.:A condition or state at a particular time.","longName":"C62780:C94226:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematologic","conceptCode":"C62780","definition":"Pertaining to or related to the blood and blood-forming organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Improvement","conceptCode":"C94226","definition":"A condition superior to an earlier condition.","evsSource":"CTCAE_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EDF7C3AA-761C-BD85-E040-BB89AD43728D","latestVersionIndicator":"Yes","beginDate":"2013-12-20","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-12-20","modifiedBy":"ONEDATA","dateModified":"2013-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A13A9B-1C7E-6586-E040-BB89AD431A0E","latestVersionIndicator":"Yes","beginDate":"2009-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2009-10-23","modifiedBy":"SOKKERL","dateModified":"2019-07-22","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964931","version":"1","longName":"2014r1: MDS Pre-HSCT Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"mds_base_prep_st_hi_cell","type":"NMDP_FN","context":"NHLBI"},{"name":"mds_base_tx_resp_cell_sp","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedClinicalResult:value","type":"HCT_BRIDG","context":"NHLBI"},{"name":"PreTed_prime_dis_hct_cell_line_type","type":"NMDP_FN","context":"NHLBI"},{"name":"MDSpre_dis_assess_prep_cell_line_type","type":"NMDP_FN","context":"NHLBI"},{"name":"MDSpre_therapy_multi_cell_line_type","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_MDS_cell_line_type","type":"NMDP_FN","context":"NHLBI"},{"name":"Theradex","type":"USED_BY","context":"Theradex"},{"name":"SCT_LAB_PRO_HEM_STAT","type":"OID, Theradex","context":"Theradex"}],"ReferenceDocuments":[{"name":"What is the hematologic impro","type":"Preferred Question Text","description":"What is the hematologic improvement status of the hematopoietic cell laboratory procedure performed?","url":null,"context":"NHLBI"},{"name":"Specify cell line:","type":"Alternate Question Text","description":"Specify cell line:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2955919","type":"BRIDG Mapping Path","description":"PerformedClinicalResult.Value(ANY=>CD) WHERE PerformedClinicalResult > PerformedObservation > DefinedObservation.nameCode = \"Specify Cell Line\"","url":null,"context":"NHLBI"},{"name":"Specify the cell line examined to determine HI status","type":"Application Standard Question Text","description":"Specify the cell line examined to determine HI status","url":null,"context":"NHLBI"},{"name":"Specify the cell line examined to determine HI status","type":"Alternate Question Text","description":"Specify the cell line examined to determine HI status","url":null,"context":"NHLBI"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Hematologic improvement","url":null,"context":"Theradex"},{"name":"Specify the cell line(s) examined to determine HI status","type":"Alternate Question Text","description":"Specify the cell line(s) examined to determine HI status","url":null,"context":"NHLBI"},{"name":"NMDP Text","type":"Alternate Question Text","description":"Specify the cell lines examined to determine HI status","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"76A0DDBD-300F-7516-E040-BB89AD435BEF","latestVersionIndicator":"Yes","beginDate":"2009-10-23","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2009-10-23","modifiedBy":"KUMMEROA","dateModified":"2022-05-23","changeDescription":". Added human readable def. System generated def displayed as alt def. No version needed. AK 10/26/14. AQT added for 2402r6. 02/24/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}